XXII — 22nd Century Share News
0.000.00%
Last trade - 00:00- $1.60m
- -$7.35m
- $17.59m
22nd Century Group falls after reverse stock split announcement
Brief: 22nd Century Announces 1-For-15 Reverse Stock Split
Brief: 22Nd Century Group Reports Q1 2023 Financial Results, Introduces FY 2023 Revenue Outlook
Brief: 22nd Century Group Q1 sales of USD 22 million
22nd Century Group Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: 22nd Century Group Announces Strategic License, Manufacturing And Distribution Agreement With Old Pal
22nd Century Group Inc expected to post a loss of 7 cents a share - Earnings Preview
Brief: 22Nd Century Group Announces Fully Integrated, Single-Source Strategic License, Manufacturing And Distribution Agreement With Cookies
Brief: 22Nd Century Group Receives Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: 22nd Century Group Files For Mixed Shelf Offering Of Up To $250 Mln - SEC Filing
Brief: 22nd Century Group Enters Into A Sales Agreement With Cowen And Company
Brief: 22Nd Century Group Reports Fourth Quarter And 2022 Financial Results
22nd Century Group Inc reports results for the quarter ended in December - Earnings Summary
Brief: 22nd Century Group Reports Q4 Shr Loss $0.12
22nd Century Group Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: 22nd Century Group Inc Enters Into Securities Purchase Agreement
Brief: 22Nd Century Group (Xxii) Secures $21 Million Debt Financing To Expand Working Capital For Growth Initiatives
22nd Century Group Inc expected to post a loss of 6 cents a share - Earnings Preview
Brief: 22Nd Century Group (Xxii) Acquires Rx Pharmatech Ltd, Greatly Strengthening Uk And EU Market Position